Skip to main content
. Author manuscript; available in PMC: 2016 Jun 9.
Published in final edited form as: Ear Hear. 2009 Apr;30(2):250–261. doi: 10.1097/AUD.0b013e3181986dfe

TABLE 1.

Subject demographics, device details, and any medical or procedural issues

Subject Gender Ear Age at implantation (mo) Age at first visit (mo) Implant Strategy Pulse rate per channel (pulses/sec) Pulse width (μsec) Stimulating electrode Special issues
s1 F L 13 26 Cochlear Freedom™ ACE (RE) 2400, 1800* 12, 20* E15, E8, E20 28 wk premature; multiple health problems at birth
s2 M L 16 25 AB HiRes 90K® HiRes-P 3480 18 E6, E16 Malformed cochleae
s3 M R 12 14 Freedom ACE (RE) 1800 20 E15, E8
s4 F L 14 21 HiRes 90K HiRes-P 5156 10.8 E7, E3 Microcephaly
s5 M R 18 32 Freedom ACE (RE) 1800 20 E16, E11 Used OPP + VROCA
s6 M B 10 14 MED-EL PulsarCI100 CIS+ 1515.2 24.2 Not tested Implant-in-a-box unavailable
s7 F R 12 16 Freedom ACE (RE) 1800 20 Not tested See results
s8 M R 9 15 Freedom ACE 900 25 E16
s9 M B/R 14 20 Freedom ACE (RE) 2400 12 E16 32 wk premature
s10 M L 12 15 Freedom ACE 900 25 E16
s11 M R 9 11 HiRes 90K HiRes-P 5156 11.7 E7
s12 M L 20 27 HiRes 90K HiRes-P w/Fidelity 120 3712 18 E7 Trisomy 9p
*

Subject was remapped across multiple visits.

Did not see any consistent response to specified electrode(s).

s9 is a bilateral recipient; only the R ear was tested.